Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice.

Infantile hemangioma is a benign endothelial tumor composed of disorganized blood vessels. It exhibits a unique life cycle of rapid postnatal growth followed by slow regression to a fibrofatty residuum. Here, we have reported the isolation of multipotential stem cells from hemangioma tissue that give rise to hemangioma-like lesions in immunodeficient mice. Cells were isolated based on expression of the stem cell marker CD133 and expanded from single cells as clonal populations. The CD133-selected cells generated human blood vessels 7 days after implantation in immunodeficient mice. Cell retrieval experiments showed the cells could again form vessels when transplanted into secondary recipients. The human vessels expressed GLUT-1 and merosin, immunodiagnostic markers for infantile hemangioma. Two months after implantation, the number of blood vessels diminished and human adipocytes became evident. Lentiviral expression of GFP was used to confirm that the hemangioma-derived cells formed the blood vessels and adipocytes in the immunodeficient mice. Thus, when transplanted into immunodeficient mice, hemangioma-derived cells recapitulated the unique evolution of infantile hemangioma--the formation of blood vessels followed by involution to fatty tissue. In summary, this study identifies a stem cell as the cellular origin of infantile hemangioma and describes for what we believe is the first time an animal model for this common tumor of infancy.

[1]  Song Yu,et al.  A Novel In Vivo Model of Human Hemangioma: Xenograft of Human Hemangioma Tissue on Nude Mice , 2007, Plastic and reconstructive surgery.

[2]  Joyce Bischoff,et al.  In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. , 2007, Blood.

[3]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[4]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[5]  C. Marras,et al.  Glioblastoma‐derived tumorospheres identify a population of tumor stem‐like cells with angiogenic potential and enhanced multidrug resistance phenotype , 2006, Glia.

[6]  E. Boscolo,et al.  Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. , 2006, Blood.

[7]  J. Mulliken,et al.  Mesenchymal Stem Cells and Adipogenesis in Hemangioma Involution , 2006, Stem cells.

[8]  M. Friedlander,et al.  Myeloid cells in infantile hemangioma. , 2006, The American journal of pathology.

[9]  P. Steijlen,et al.  The Pathogenesis of Hemangiomas: A Review , 2006, Plastic and reconstructive surgery.

[10]  Gabriel S. Eichler,et al.  Evidence by molecular profiling for a placental origin of infantile hemangioma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  N. Maitland,et al.  Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.

[12]  F. Schweizer,et al.  Neuronal Differentiation of Bone Marrow-derived Stromal Stem Cells Involves Suppression of Discordant Phenotypes through Gene Silencing* , 2005, Journal of Biological Chemistry.

[13]  S. Rafii,et al.  AC133/CD133/Prominin-1. , 2005, The international journal of biochemistry & cell biology.

[14]  L. Olson,et al.  Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. , 2004, Carcinogenesis.

[15]  L. Lagneaux,et al.  Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. , 2004, Differentiation; research in biological diversity.

[16]  K. Preissner,et al.  Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood , 2004, Thrombosis and Haemostasis.

[17]  Joyce Bischoff,et al.  Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. , 2004, American journal of physiology. Heart and circulatory physiology.

[18]  D. Neal,et al.  CD133, a novel marker for human prostatic epithelial stem cells , 2004, Journal of Cell Science.

[19]  J. Mulliken,et al.  Endothelial progenitor cells in infantile hemangioma. , 2004, Blood.

[20]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[21]  N. Callander,et al.  AML-1A and AML-1B regulation of MIP-1α expression in multiple myeloma , 2003 .

[22]  Y. Tabata,et al.  Time course of de novo adipogenesis in matrigel by gelatin microspheres incorporating basic fibroblast growth factor. , 2002, Tissue engineering.

[23]  J. Bischoff Monoclonal expansion of endothelial cells in hemangioma: an intrinsic defect with extrinsic consequences? , 2002, Trends in cardiovascular medicine.

[24]  C. Verfaillie,et al.  Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.

[25]  M. Mihm,et al.  Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. , 2001, Archives of dermatology.

[26]  M. Mihm,et al.  A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. , 2001, Archives of dermatology.

[27]  J. Mulliken,et al.  Clonality and altered behavior of endothelial cells from hemangiomas. , 2001, The Journal of clinical investigation.

[28]  J. Reinisch,et al.  In vitro characteristics of neonatal hemangioma endothelial cells: similarities and differences between normal neonatal and fetal endothelial cells , 2000, Journal of cutaneous pathology.

[29]  Y. Ikada,et al.  De novo formation of adipose tissue by controlled release of basic fibroblast growth factor. , 2000, Tissue engineering.

[30]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[31]  C. Bucana,et al.  Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. , 1999, International journal of oncology.

[32]  M. Kennedy,et al.  A common precursor for hematopoietic and endothelial cells. , 1998, Development.

[33]  E. Nicodemou-Lena,et al.  De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Wassef,et al.  Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. , 1997, The American journal of pathology.

[35]  Y. Iwamoto,et al.  A quantitative assay using basement membrane extracts to study tumor angiogenesis in vivo , 1996, International journal of cancer.

[36]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[37]  B. Smoller,et al.  Infantile (juvenile) capillary hemangioma: A tumor of heterogeneous cellular elements , 1993, Journal of cutaneous pathology.

[38]  A. Greenberg,et al.  Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. , 1991, The Journal of biological chemistry.

[39]  D. Mason,et al.  JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. , 1990, Journal of clinical pathology.

[40]  R. Auerbach,et al.  A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[41]  D. Hanahan,et al.  Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene , 1987, Cell.

[42]  L. Cotton Vascular malformations (Angiodysplasias). Edited E. Malan, Milan. 240 × 170 mm. Pp. 213, with 176 illustrations. 1974. Milan: Carlo Erba Foundation. No price given , 1975 .

[43]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2007, Nature.

[44]  N. Speck,et al.  Runx1 function in hematopoiesis is required in cells that express Tek. , 2006, Blood.

[45]  E. Christison-Lagay,et al.  Vascular anomalies. , 2006, The Surgical clinics of North America.

[46]  D. Senger,et al.  In vivo and in vitro models of Mammalian angiogenesis. , 2005, Methods in molecular biology.

[47]  N. Callander,et al.  AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma. , 2003, Blood.

[48]  M. Mihm,et al.  GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. , 2000, Human pathology.

[49]  R. Virchow,et al.  Die krankhaften Geschwülste , 1978 .

[50]  G. Pack,et al.  Hemangiomas; classification, diagnosis and treatment. , 1950, Angiology.

[51]  R. Virchow Die krankhaften Geschwülste : dreissig Vorlesungen, gehalten während des Wintersemesters 1862-1863 an der Universität zu Berlin , 1863 .